Changes

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, PORTUGAL

Instead of:

[...]

IV.4.3) Time-limit for the submission of applications:

Date: 17.5.2019

[...]

Read:

[...]

IV.4.3) Time-limit for the submission of applications:

Date: 24.5.2019

[...]

Deadline Date2019-05-24
Publication Date2019-04-23
CountryPortugal
Procurement StatusAmended
TypeNot specified
Contract TypeServices
Award CriteriaNot applicable
OrganisationEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
TownLisbon
Class Code79621000
Class DescriptionSupply services of office personnel
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)

Version of 2019-04-15

Call for expressions of interest in membership of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction

ChangesSection I: Contracting authorityI.1)Name, addresses and contact point(s)

Official name: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, PORTUGAL

National ID: PT

Postal address: Praça Europa 1, Cais do Sodré

Town: Lisbon

Postal code: 1249-289

Country: Portugal (PT)

Contact point(s)

For the attention of: Vivianne Rodriguez, Procurement Officer

Telephone: +351 211210298

Fax: +351 210193502

E-mail: info.procurement@emcdda.europa.eu

Internet address(es)

General address of the contracting authority (URL): http://www.emcdda.europa.eu

Electronic access to information (URL): http://www.emcdda.europa.eu/about/sc/call-scientific-committee-2019

Electronic submission of applications (URL): SciCom19@emcdda.europa.eu

Further information can be obtained from:

The above mentioned contact point(s)

Specifications and additional documents can be obtained from:

The above mentioned contact point(s)

Applications must be sent to:

The above mentioned contact point(s)

I.2)Type of the contracting authority

European institution/agency or international organisation

I.3)Main activity

Other: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: no

Section II: Object of the call for expressions of interestII.1)Title attributed to the call for expressions of interest

Call for expressions of interest in membership of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction

II.2)Type of contract and location of works, place of delivery or of performance

Services

Service category No: 27 Other services

Main site or location of works, place of delivery or of performance: EMCDDA in Lisbon, Portugal

NUTS code: PT17

II.3)Description of the field or fields covered by the call for expressions of interest:

This call is addressed to scientists who wish to be considered for membership of the EMCDDA Scientific Committee.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), based in Lisbon, PORTUGAL, was established to provide the European Union and its Member States with 'factual, objective, reliable and comparable information at European level concerning drugs and drug addiction and their consequences' (1). For additional information on the EMCDDA, please see http://www.emcdda.europa.eu.

EMCDDA Scientific Committee

The EMCDDA Scientific Committee is set up by Article 13 of the Regulation (EC) No 1920/2006 of the European Parliament and of the Council on the European Monitoring Centre for Drugs and Drug Addiction (recast) (1).

The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it.

In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) (2). In carrying out the risk assessment of new psychoactive substances, the Scientific Committee (extended, as required) needs to be able to assess public health and social risks posed by new psychoactive substances.

The Scientific Committee consists of, at most, 15 well-known scientists appointed by the Management Board in view of their scientific excellence and their independence. The members of the Scientific Committee shall be appointed for a three-year period, which shall be renewable, in a personal capacity and shall give their opinions completely independently of the Member States and the European Union Institutions (3). They shall possess proven scientific excellence, both in terms of experience and expertise, in relation to the fields of the mandate of the EMCDDA, namely:

(a) basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research, pharmacology and toxicology);

(b) population-based research and epidemiology (including surveys and ethnographic studies);

(c) demand reduction (including prevention, treatment, harm reduction and reintegration);

(d) supply, supply reduction and crime;

(e) drug policy (including laws, economic issues and strategies).

Upon appointment, each member of the EMCDDA Scientific Committee shall sign a declaration of independence in relation to the performance of his/her duties in and for this body and shall fill in and sign a written declaration of interest covering current and past interests up to five years before the date of the declaration. These declarations will be made available for public scrutiny on the EMCDDA website, with due respect to EU rules on protection of personal data.

Meetings of the Scientific Committee are generally held twice a year at the EMCDDA premises in Lisbon. The vehicular working language of the Scientific Committee is English. Members are expected to attend these meetings, as well as risk assessment meetings in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). If a member does not attend two consecutive regular Scientific Committee meetings, the membership may be withdrawn.

Members of the Scientific Committee will be entitled to an indemnity for each meeting day. Members will also receive travel and subsistence allowance in accordance with the EMCDDA’s policy for the reimbursement of travel and accommodation expenses.

The rules applicable to the EMCDDA Scientific Committee require that its members are nationals of a Member State of the European Union (EU) or of a Country which has concluded an agreement with the latter for the purpose of the participation in the work of the EMCDDA. This requirement is a condition of eligibility for the selection and the appointment of the members of the EMCDDA Scientific Committee. If this condition is not met, this will determine the exclusion of the concerned person from the selection process and/or the termination of his/her appointment as member of the EMCDDA Scientific Committee, from the moment when the above referred condition is not met.

With regard to the above, and by taking into account the on-going process concerning the withdrawal of the United Kingdom (UK) from the EU (Brexit), United Kingdom’s nationals will no longer satisfy this condition as of the date of this withdrawal, to be determined in accordance with Article 50 of the Treaty of the European Union (TFEU). However, if at this date the Agreement to be concluded between the EU and the UK on this withdrawal (Withdrawal Agreement, as endorsed by the European Council on 25.11.2018) enters into force, United Kingdom’s nationals will be considered to meet the aforementioned condition of nationality during the transition period established by this Agreement.

Further information on this call, including procedures, arrangements and the requirements for eligibility and selection, are available from the EMCDDA website http://www.emcdda.europa.eu/about/sc/call-scientificcommittee-2019

Applications shall be sent to SciCom19@emcdda.europa.eu.

Closing date:

The closing date for submission of applications is 17.5.2019 at 23:59, Lisbon time (date and hour of e-mail). The EMCDDA reserves the right to disregard any expressions of interest sent after that date.

(1) OJ L 376, 27.12.2006, p. 1. See: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2006:376:TOC

(2) OJ L 305, 21.11.2017, p. 1–7. See: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2017.305.01.0001.01.ENG

(3) Information on the current composition of the EMCDDA Scientific Committee, agendas and minutes of meetings, adopted formal opinions and rules of procedure are available on http://www.emcdda.europa.eu/about/sc

II.4)Information about lots (for information about lots, use Annex B as many times as there are lots)

This call for expressions of interest is divided into lots: no

Applications may be submitted for: one lot only

II.5)Information about subcontracting

The subcontracting is accepted: no

Section IV: ProcedureIV.1)Type of procedure

Restricted

IV.2)Grounds for exclusion

Applicants shall be excluded from participating in a contract if:

(a) they are bankrupt, being wound up or have suspended business activities, their affairs are being administered by the court, they have entered into an arrangement with creditors or similar measures or are the subject of any proceedings of that nature, or are in any analogous situation arising from a similar procedure provided for in national legislation or regulations;

(b) they have been convicted of an offence concerning their professional conduct by a judgment which is not open to appeal;

(c) they have been guilty of grave professional misconduct;

(d) they have not fulfilled obligations relating to the payment of social security contributions or taxes;

(e) they are guilty of serious misrepresentation in supplying the information required by the authorizing department;

(f) other: n/a.

IV.3)Selection criteria:

Procedures and arrangements for the selection and appointment of the members of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) are available at: http://www.emcdda.europa.eu/about/sc/call-scientific-committee-2019

IV.4)Administrative information

IV.4.1) File reference number:

SciCom19

IV.4.2) Period of validity of the list resulting from this call for expressions of interests:

Expiry date of the list resulting from the call for expressions of interest:

Date: 31.12.2022

IV.4.3) Time-limit for the submission of applications:

Date: 17.05.2019

IV.4.4) Language(s) in which applications may be submitted:

Official EU language(s): English

Section VI: Complementary informationVI.3)Date of dispatch of this notice:

3.4.2019

Deadline Date2019-05-17
Publication Date2019-04-15
CountryPortugal
Procurement StatusActive
TypeNot specified
Contract TypeServices
Award CriteriaNot applicable
OrganisationEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
TownLisbon
Class Code79621000
Class DescriptionSupply services of office personnel
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)

Related Procurements

Deadline: May 18, 2019
Aquisição de processadores IFL (Integrated Facility for Linux) para os equipamentos Mainframe dos centros de dados primário e secundário da AT.
View more
Deadline: May 20, 2019
Aquisição de géneros alimentícios (mercearias) para confecionar as refeições a servir pelas messes da unidade de apoio de Lisboa no quadrimestre de junho a setembro de 2019.
View more
Deadline: May 18, 2019
Aquisição serviços viagens, transportes aéreos e alojamentos para a SGAI e Gabinetes.
View more